The United States is not immune from the risks associated from substandard and knock-off medications, according to a new report by the Institute of Medicine. While the risks are exponentially greater in developing countries, the report warns federal regulators that counterfeit drugs are a deadly reality in America as well. In the four months from September 2012 to January 2013, "negligent production" by a Massachusetts pharmacy sickened 600 people and killed 44, according to the Institute of Medicine of the National Academies.
